A director at Merck & Co., Inc. (NYSE:MRK) has made a significant stock purchase, according to a Form 4 filing with the Securities and Exchange Commission.
At publication ·
Merck & Co., Inc. (NYSE:MRK) · large purchase
At a glance
A director at Merck & Co., Inc. (NYSE:MRK) has made a significant stock purchase, according to a Form 4 filing with the Securities and Exchange Commission.
Zachary Jennifer, serving as , purchased 125,824 shares on August 12, 2026 at an average price of $84.71 per share. The total transaction was valued at $1.1M.
Following this transaction, Zachary Jennifer now owns 125,824 shares of Merck & Co., Inc. stock. Merck & Co., Inc.'s stock currently trades at $135.97.
Insider purchases are widely considered one of the most reliable bullish indicators in equity markets. Unlike selling — which can happen for personal financial reasons — buying requires the insider to commit their own capital, suggesting genuine confidence in the company's future. When a buys shares, they're betting their own money on outcomes they have direct visibility into.
At $1.1 million, this transaction stands out as a significant commitment. Trades of this size from corporate insiders typically attract attention from institutional investors and analysts who track Form 4 filings for early signals about company direction.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around Merck & Co., Inc.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | Guindo Chirfi | Sell | 36,613 | $1.4 million |
| Aug 12, 2026 | Zachary Jennifer | Sell | 0 | |
| Aug 12, 2026 | Zachary Jennifer | Sell | 0 | |
| Aug 12, 2026 | Zachary Jennifer | Sell | 45,509 | $10.7 million |
| Aug 12, 2026 | Zachary Jennifer | Buy | 125,824 | $1.1 million |
Related Tools: Insider Trades Tracker | View MRK Stock Page
Insider large_purchases at Merck & Co., Inc. (NYSE:MRK) are reported to the SEC via Form 4 filings. While a single transaction doesn't predict future stock performance, patterns of insider buying can signal management confidence.
Monitor all insider transactions on the MRK insider trades page or the Insider Trades Tracker.
Current market data
NYSE · MRK
$148.99
Up: +$3.88 · +2.60%
Live quote updated
Keep reading
